Kenny Walter

In data presented at AAD, investigators found increased odds of GERD in patients with rosacea compared to a control group without rosacea.

The prevalence of NAFLD in the pediatric population has increased in recent years.

A multi-disciplinary approach could help better manage obesity following bariatric surgery.

The treatment represents the only FDA approved orally dissolving sublingual film for this patient population.

April 6 is Donate Life Living Donor Day, a day to promote liver donations.

The guidelines focus on diagnosing and screening for Barrett’s esophagus and esophageal adenocarcinoma.

Patients with irritable bowel syndrome more frequently self-reported non-celiac gluten sensitivity compared to the control group, as well as major gastrointestinal symptoms found in the study included bloating, abdominal discomfort, and belching.

There was an adequate response for pediatric patients on biologics to the H1N1 and H3N2 serotypes.

Using a main adjusted model, the investigators found an increase of 31.8 percentage points in test completion in the intervention group compared to the control group.

There are now more insulin options for patients with diabetes than ever before.

The guidelines replace risk-based reccomendations for adults between 19-59 years.

The costs related to Medicare for OACC increased by about 4% between 2012-2017 for patients with end-stage kidney disease for kidney transplantation.

The agency cited an increased risk of thromboembolic events driven by vascular access thrombosis in dialysis patients and increased risk of drug-induced liver injuries.

Males between 50-64 who have been vaccinated without erythema were at the highest risk of GBS.

Nearly all of the doctors polled recommended the pneumococcal vaccine for patients with cardiovascular disease aged 65 years and older.

Human milk oligosaccharides could help treat some of the gut disruptions patients with depression often have.

Fecal microbiota transplantation is known to cure up to 88% of patients with recurrent C difficile infections.

The relative risk of hospitalization was substantially lower for patients with IBD and COVID-19 who were treated with biologics (compared to patients not treated with biologics.

The advent of biologics has transformed care for patients with inflammatory bowel disease.

There is a need to study more combination therapies for the treatment of inflammatory bowel disease.

RBX2660 is a live microbiome therapeutics that could build on the success of fecal microbiota transplantation for treating patients with recurrent C difficile infections.

There was an independent association between in-hospital mortality and a neutrophil ratio greater than 75%, serum creatinine of at least 1.5 mg/L, and CDI caused by isolates harboring the tcdC gene.

Investigators found 31% of patients treated with aldafermin 0.3 mg had an improvement in liver fibrosis of at least 1 stage with no worsening of NASH.

The investigators assessed and validated 3 rule-based algorithms for C difficile infection detection.

The abundance of ribotype 027 was low, while the prevalence of RT001 declined from 12.3% to 3.7% during the three-year study period.

For patients treated with DOACs, the investigators suggest temporarily interrupting treatment rather than continued use.

Upadacitinib is now approved for ulcerative colitis, atopic dermatitis, and psoriatic arthritis.

The hope is society learns some of the lessons from the Cold War to better help patients with mental health concerns.

The decision represents the first ever upadacitinib for a gastroenterological disease.

Social media has had an influence on the mental health toll the war in the Ukraine is having.